Evelo Biosciences CEO Balkrishan Gill's 2020 pay falls 23% to $2.2M
Evelo Biosciences reports 2020 executive compensation
By ExecPay News
Published: April 26, 2021
Evelo Biosciences reported fiscal year 2020 executive compensation information on April 26, 2021.
In 2020, three executives at Evelo Biosciences received on average a compensation package of $1.5M, a 21% decrease compared to previous year.
Average pay of disclosed executives at Evelo Biosciences
Balkrishan Simba Gill, Chief Executive Officer, received $2.2M in total, which decreased by 23% compared to 2019. 56% of Gill's compensation, or $1.2M, was in option awards. Gill also received $400K in non-equity incentive plan and $560K in salary.
Duncan McHale, M.B.B.S., Chief Medical Officer, received a compensation package of $1.2M. 46% of the compensation package, or $565K, was in option awards.
Mark Bodmer, Chief Scientific Officer, earned $1.2M in 2020, a 23% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 26, 2021.